BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8540292)

  • 1. Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome.
    Pucci E; Genazzani AD; Monzani F; Lippi F; Angelini F; Gargani M; Barletta D; Luisi M; Genazzani AR
    Gynecol Endocrinol; 1995 Sep; 9(3):221-8. PubMed ID: 8540292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
    De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A
    Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
    Falsetti L; De Fusco D; Eleftheriou G; Rosina B
    Gynecol Endocrinol; 1997 Aug; 11(4):251-7. PubMed ID: 9272421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hirsutism in women with flutamide.
    Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
    Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of finasteride versus flutamide in the treatment of hirsutism.
    Falsetti L; Gambera A; Legrenzi L; Iacobello C; Bugari G
    Eur J Endocrinol; 1999 Oct; 141(4):361-7. PubMed ID: 10526249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Finasteride and flutamide in the treatment of hirsutism].
    Falsetti L; De Fusco D; Rosina B
    Minerva Ginecol; 1997 Oct; 49(10):463-8. PubMed ID: 9463180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism.
    Müderris II; Bayram F
    J Endocrinol Invest; 1999 Mar; 22(3):165-8. PubMed ID: 10219882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
    Ciotta L; Cianci A; Marletta E; Pisana L; Aglianò A; Palumbo G
    Fertil Steril; 1994 Dec; 62(6):1129-35. PubMed ID: 7957975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism.
    Paoletti AM; Cagnacci A; Orrù M; Ajossa S; Guerriero S; Melis GB
    Fertil Steril; 1999 Sep; 72(3):448-53. PubMed ID: 10519615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism.
    Dikensoy E; Balat O; Pence S; Akcali C; Cicek H
    Arch Gynecol Obstet; 2009 Mar; 279(3):321-7. PubMed ID: 18607612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior.
    Moghetti P; Castello R; Negri C; Tosi F; Magnani CM; Fontanarosa MC; Armanini D; Muggeo M
    Fertil Steril; 1995 Sep; 64(3):511-7. PubMed ID: 7641903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).
    De Leo V; la Marca A; Lanzetta D; Cariello PL; D'Antona D; Morgante G
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):85-9. PubMed ID: 9797851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day).
    Müderris II; Bayram F; Güven M
    Gynecol Endocrinol; 2000 Feb; 14(1):38-41. PubMed ID: 10813105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
    Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S
    Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of flutamide alone or combined with oral contraceptives in the treatment of hirsutism in women].
    Devoto E; Aravena L
    Rev Med Chil; 2004 Jul; 132(7):845-52. PubMed ID: 15379332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome.
    Boztosun A; Açmaz G; Ozturk A; Müderris II
    Ginekol Pol; 2013 Apr; 84(4):258-62. PubMed ID: 23700857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism.
    Müderris II; Bayram F; Güven M
    Fertil Steril; 2000 May; 73(5):984-7. PubMed ID: 10785225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-receptor blockade does not impair bone mineral density in adolescent females.
    Bertelloni S; Baroncelli GI; Sorrentino MC; Costa S; Battini R; Saggese G
    Calcif Tissue Int; 1997 Jul; 61(1):1-5. PubMed ID: 9192502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.